Study S000989

The Association Between Weight Loss With Subsequent Maintenance Using Liraglutide and Changes in Skin Autoflouresence in Overweight or Obese Patients With Knee Osteoarthritis - a Substudy to "Effect of Liraglutide on Body Weight and Pain in Overweight or Obese Patients With Knee Osteoarthritis: A Randomised, Double Blind, Placebo-controlled, Parallel Group, Single-centre Trial" (NCT02905864)

ClinicalTrials.gov record

Registration

Registration: NCT02910570
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 150
Start: 2016-11
Primary completion: 2019-02
Lead sponsor: Parker Research Institute
Conditions: Osteoarthritis, Knee
Interventions: DRUG:Liraglutide 3 mg (Saxenda); DRUG:Liraglutide 3 mg placebo
Results posted: FALSE

Registered primary outcomes

Change in advanced glycation end products in the skin [week 0 to 52]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.